Research Article
Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical Study
Table 3
Adverse events.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
value, comparison between the treatment group and the control group. < 0.05 indicates a significant difference. [1]Definition of severity: mild, confirmed cases with fever (measured or subjective) or respiratory symptoms; moderate, confirmed cases with fever (measured or subjective) or respiratory symptoms and radiographic evidence of pneumonia; severe, confirmed cases with evidence including fever, respiratory symptoms, radiographic evidence of pneumonia, and at least one of the following symptoms: respiratory distress, RR ≥30 times/min; resting state, mean oxygen saturation ≤93%; and PaO2/FiO2 ≤ 300 mmHg (1 mmHg = 0.133 kPa). |